Valuation (16%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.45 | N/A |
PEG Ratio (TTM) | -0.03 | N/A |
P/S Ratio (TTM) | 18.34 | N/A |
P/B Ratio (TTM) | 0.46 | N/A |
P/FCF Ratio (TTM) | -0.37 | N/A |
Price to 5YR AVG Earnings Ratio | -0.21 | N/A |
Price to 5YR AVG FCF Ratio | -0.54 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -36.83% | N/A |
ROE (TTM) | -88.92% | N/A |
Net Profit Margin (TTM) | -3,975.27% | N/A |
ROIC 5YR AVG | -105.22% | N/A |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 15.52% | -685.13% | -413.39% |
Revenue | 13.84% | 407.40% | 277.31% |
Net Income | 7.77% | -694.13% | -424.91% |
Cash Flow | 1.73% | -5,888.56% | -3,549.66% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 4.52 | N/A |
Quick Ratio (TTM) | 4.52 | N/A |
D/E Ratio (TTM) | 1.15 | N/A |
Interest Coverage (TTM) | -31.67 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -1.31 | N/A |
Shares Outstanding Growth 5YR AVG | 12.10% | N/A |